# Higher Dose of Alglucosidase Alpha for Pompe Disease

> **NCT05017402** · — · NOT_YET_RECRUITING · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 36 (estimated)

## Conditions studied

- Glycogen Storage Disease Type II

## Interventions

- **DRUG:** Alglucosidase Alfa

## Key facts

- **NCT ID:** NCT05017402
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-09-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017402, "Higher Dose of Alglucosidase Alpha for Pompe Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05017402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*